Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Koshi Araki is active.

Publication


Featured researches published by Koshi Araki.


British Journal of Cancer | 2000

Prognostic factors in patients with submucosal carcinoma of the oesophagus

Masayuki Watanabe; Hiroyuki Kuwano; Koshi Araki; Hidetoshi Kawaguchi; Hidehisa Saeki; Kaoru Kitamura; Shinji Ohno; Keizo Sugimachi

To clarify the prognostic factors in patients with submucosal carcinoma of the oesophagus, we examined the results of surgical treatment for 78 cases over the last decade. The clinicopathological factors including age, sex, location of the tumour, length of the tumour, histological differentiation, subclassification of depth, lymphatic or blood vessel invasion, intramural metastasis and lymph node metastasis were all analysed. Then the correlation between these factors and prognosis was investigated. As a result, significant differences were observed in the survival rates between the groups regarding lymphatic vessel invasion (P = 0.0003), intramural metastasis (P = 0.0051) and lymph node metastasis (P = 0.0026). According to a multivariate analysis, intramural metastasis (P = 0.0038, relative risk 9.17), vessel invasion (P = 0.0033, relative risk 6.25) and lymph node metastasis (P = 0.0187, relative risk 3.62) were found to be independent prognostic factors. The prognosis of the patients with at least one of these factors was significantly poorer than that without. The five-year survival rate of the patients without these factors was as good as that with mucosal carcinoma of the oesophagus. Based on our findings, vessel invasion, intramural metastasis and lymph node metastasis are thus considered to be significant prognostic factors in patients with submucosal carcinoma of the oesophagus.


British Journal of Cancer | 2000

Alcohol consumption and cigarette smoking in relation to high frequency of p53 protein accumulation in oesophageal squamous cell carcinoma in the Japanese.

Hiroshi Saeki; Shinji Ohno; Koshi Araki; Akinori Egashira; Hidetoshi Kawaguchi; Yasuharu Ikeda; Masaru Morita; Kaoru Kitamura; Keizo Sugimachi

We investigated levels of p53 protein expression in Japanese patients with oesophageal squamous cell carcinoma. A significantly larger proportion of heavy alcohol drinkers and cigarette smokers was evident in the p53-positive group. The combination of drinking and smoking was associated with a high frequency of p53 protein accumulation.


Oncology | 2002

p53 protein accumulation in multiple oesophageal squamous cell carcinoma: relationship to risk factors.

Hiroshi Saeki; Shinji Ohno; Mitsuhiro Miyazaki; Koshi Araki; Akinori Egashira; Hidetoshi Kawaguchi; Masayuki Watanabe; Masaru Morita; Keizo Sugimachi

To clarify mechanisms involved in the carcinogenesis of multiple oesophageal squamous cell carcinoma, the expression of p53 protein in 46 lesions surgically excised from 13 Japanese patients was investigated immunohistochemically and the relation of p53 protein accumulation to the patient’s history of alcohol consumption and cigarette smoking was analyzed. p53 protein accumulation was observed in 13 main lesions, that is in 6 (85.7%) of 7 subjects with a history of heavy drinking and smoking, but only in 1 (16.7%) of 6 with no such history (Fisher’s exact test, p = 0.025). As regards the 46 lesions, p53 protein accumulation was evident in 22 (88.0%) of 25 lesions of the high-risk patients, but in 7 (33.3%) of 21 lesions of the other subjects (Fisher’s exact test, p < 0.001). p53 protein accumulation was similarly recognized in all oesophageal lesions in 5 of 7 high-risk patients. Thus, use of both alcohol and cigarettes is clearly associated with a high frequency of p53 protein accumulation in multiple oesophageal squamous cell carcinoma present at the same time. These findings are considered to support the concept of field carcinogenesis of the oesophagus.


International Journal of Hyperthermia | 1998

Clinicopathologic Features of Patients with Oesophageal Cancer Obtaining a Histological Complete Response for Preoperative Hyperthermo-Chemo-Radiotherapy

Kaoru Kitamura; Hiroyuki Kuwano; Koshi Araki; Akinori Egashira; Hidetoshi Kawaguchi; Hidehisa Saeki; Masaru Morita; Shinji Ohno; Sugimachi K

From 1979 to 1993, 151 patients with resectable oesophageal cancer underwent preoperative hyperthermo-chemo-radiotherapy (HCR) followed by a subtotal esophagectomy. All resected specimens were histopathologically evaluated, and then were classified into two groups according to the efficacy of the preoperative HCR. Group A included 33 patients whose resected oesophagus was free of any cancer cells (grade 3). Group B included 118 patients, in which viable cancer cells remained in the resected specimens to various degrees (grade 1,2). The incidence of patients with well differentiated squamous cell carcinoma, node negative cases, or TNM stage I/II was significantly higher in group A than in group B (27.3% versus 9.3%, 72.7% versus 50.8%, 72.7% versus 50.8%, respectively). The recurrence rate was 33.3% (11/33) in group A, while it was 65.3% (77/118) in group B (p < 0.005). There was no case with any local recurrence in the former, while it was 8.5% (10/118) in the latter. The 1-, 3- and 5-year survival rates were 87.2%, 65.9% and 46.1% in group A, while they were 54.8%, 26.7% and 18.8% in group B (p < 0.005), respectively. Preoperative HCR may be expected of decreasing in the recurrence rate, including regional relapse when a grade 3 is obtained. Complete local control would further positively influence the prognosis.


Surgery Today | 1999

Esophageal carcinoma showing a long stricture due to prominent lymphatic permeation: Report of a case

Hidetoshi Kawaguchi; Hiroyuki Kuwano; Koshi Araki; Akinori Egashira; Hiroshi Saeki; Takefumi Ohga; Masaru Morita; Kaoru Kitamura; Keizo Sugimachi

Some esophageal diseases such as carcinoma, esophagitis, and collagen diseases have often been reported to show a diffusely thickened esophageal wall in the roentogenogram findings. In the current report, a preoperative upper gastrointestinal series and an endoscopic examination showed a diffusely infiltrative type carcinoma, but other examinations did not suggest any diseases such as esophagitis or collagen diseases which might cause a thickening of the esophageal wall or a constriction, of the esophagus. A postoperative histological examination revealed the primary carcinoma to remain only within the mucosal layer, while a large degree of lymphatic vessel permeation reached the adventitia over a wide area. An extraordinary degree of lymphatic permeation spread through the esophageal wall, and stromal fibrosis developed as a result of such lymphatic permeation. These histological phenomena might thus have led to the macroscopic appearance of infiltrative type esophageal carcinoma.


Cancer Research | 2000

p53 polymorphism in human papillomavirus-associated esophageal cancer.

Hidetoshi Kawaguchi; Shinji Ohno; Koshi Araki; Mitsuhiro Miyazaki; Hiroshi Saeki; Masayuki Watanabe; Shinji Tanaka; Keizo Sugimachi


Hepato-gastroenterology | 2000

IMMUNOHISTOCHEMICAL STATUS OF THE P53 PROTEIN AND KI-67 ANTIGEN USING BIOPSIED SPECIMENS CAN PREDICT A SENSITIVITY TO NEOADJUVANT THERAPY IN PATIENTS WITH ESOPHAGEAL CANCER

Kaoru Kitamura; Hidehisa Saeki; Hidetoshi Kawaguchi; Koshi Araki; Shinji Ohno; Hiroyuki Kuwano; Y. Maehara; Sugimachi K


Journal of Surgical Oncology | 2003

Risk factors for multicentric occurrence of carcinoma in the upper aerodigestive tract—analysis with a serial histologic evaluation of the whole resected-esophagus including carcinoma†

Masaru Morita; Koshi Araki; Hiroshi Saeki; Yoshihisa Sakaguchi; Hideo Baba; Keizo Sugimachi; Koichi Yano; Kenji Sugio; Kosei Yasumoto


Hepato-gastroenterology | 1999

Esophageal hemangioma: a case report and review of the literature.

Koshi Araki; Shinji Ohno; Akinori Egashira; Hidehisa Saeki; Hidetoshi Kawaguchi; Yasuharu Ikeda; Kaoru Kitamura; Keizo Sugimachi


Nihon Geka Gakkai zasshi | 1999

Treatment strategy for and clinical results in patients with recurrent esophageal cancer

Saeki H; Hidetoshi Kawaguchi; Koshi Araki; Shinji Ohno; Sugimachi K

Collaboration


Dive into the Koshi Araki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge